AI Business LensTHE BUSINESS OF AI, FOR PEOPLE WHO TEACH IT OR LEARN FROM IT
Medical Xpress · September 16, 2026 · On the brief until September 30, 2026

From 7,000 drugs to one active against resistant strains: AI advances pneumonia drug repurposing

MedicinePharmacyBiology
THE AI ANGLE
Screening drug libraries to identify candidates for antimicrobial repurposing

Researchers deployed three distinct AI architectures—ensembles of decision trees, graph neural networks, and sequence-based transformers—to screen nearly 7,000 candidate drugs for inhibitory activity against Streptococcus pneumoniae. Experimental validation of 11 selected compounds revealed that nine successfully inhibited bacterial growth, with one potent compound remaining effective against drug-resistant strains. This demonstrates the viability of multi-model computational drug repurposing as a rapid, cost-effective strategy to address urgent antimicrobial resistance.

Summary written by AI Business Lens with an AI model from the article at medicalxpress.com. It is not the article, and the publisher has not reviewed it. For publishers.

THE TEACHING ANGLE
Instructors can examine how combining diverse AI modeling techniques improves candidate selection compared to single models when repurposing existing pharmacotherapies against resistant pathogens.

Read the original at medicalxpress.com   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, class prep, and an exercise. All built from the full article. Three are free with an account. Stories stay on the brief for 14 days; after that this page keeps the link to the original.

More in Medicine